Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
12.21
-0.16 (-1.29%)
Feb 21, 2025, 4:00 PM EST - Market closed
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $313.10 million as of February 21, 2025. Its market cap has decreased by -66.87% in one year.
Market Cap
313.10M
Enterprise Value
31.46M
1-Year Change
-66.87%
Ranking
Category
Stock Price
$12.21
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $313.10M, an increase of 41.24%. That is a compound annual growth rate of 29.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 313.10M | -39.79% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |